Evidence map›Paper›PMID 40322677›Full record

ArticleClinical kidney journal2025

Postoperative mid-to-long-term adverse event prediction model for patients receiving non-cardiac surgery: An extension of the Simple Postoperative AKI RisK (SPARK) model.

Soie Kwon, Sehoon Park, Sunah Yang, Chaiho Shin, Jeonghwan Lee, Jiwon Ryu, Sejoong Kim, Jeong Min Cho, Hyung-Jin Yoon, Dong Ki Kim and 5 more

Abstract read
In one paragraph

Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Soie KwonDepartment of Internal Medicine, Chung-Ang University Seoul Hospital, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0002-0878-5469
Sehoon ParkDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Sunah YangDepartment of Clinical Medical Sciences, College of Medicine, Seoul National University, Seoul, Republic of Korea.
Chaiho ShinBio Medical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
Jeonghwan LeeDepartment of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Jiwon RyuDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seoul, Republic of Korea.
Sejoong KimDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seoul, Republic of Korea.
Jeong Min ChoDepartment of Internal Medicine, Chung-Ang University Gwangmyeong Hospital, Seoul, Republic of Korea.
Hyung-Jin YoonDepartment of Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, Republic of Korea.
Dong Ki KimDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Kwon Wook JooDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Yon Su KimDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Minsu ParkDepartment of Information and Statistics, Chungnam National University, Daejeon, Republic of Korea.
Kwangsoo KimTransdisciplinary Department of Medicine & Advanced Technology, Seoul National University Hospital, Seoul, Republic of Korea.
Hajeong LeeDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0002-1873-1587

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Postoperative acute kidney injury (PO-AKI) is a critical complication of adverse kidney outcomes, both short and long-term. We aimed to expand our pre-existing PO-AKI prediction model to predict mid-to long-term adverse kidney outcomes. Methods: We included patients who underwent major non-cardiac surgeries from the original SPARK cohort, two external validation cohorts, and a temporal validation cohort. Mid-to-long-term adverse kidney outcomes were defined as end-stage kidney disease progression or death within 1 or 3 years after surgery. We verified and tuned the original Simple Postoperative AKI RisK (SPARK) model to predict mid-to-long-term adverse kidney events. Results: We included 33 636 patients in development, 71 232 patients in external validation, and 33 944 patients in temporal validation cohorts, respectively. One- and 3-year adverse kidney events occurred in 5.5% and 13.2% in the development cohort, respectively. The original SPARK score demonstrated an acceptable discriminative power for 1-year and 3-year adverse outcome risks with C indices mostly >0.7. However, the power was relatively poor when restricted to high-risk patients or those who actually developed PO-AKI. When we re-calculated the regression coefficients from a Cox model, the discriminative performances were better, especially for those with high-risk characteristics (e.g. 1-year outcome, C-index 0.72 in developmental and 0.73‒0.77 in validation datasets). Furthermore, when the model integrated the PO-AKI stage and history of malignancy with the SPARK variables, the performance was significantly enhanced (1-year, C-index 0.86 in development and 0.86‒0.88 in validation results). With the above findings, we constructed an online postoperative risk prediction system (https://snuhnephrology.github.io/postop/). Conclusions: The addition of two clinical factors and recalibration of SPARK variables significantly improved mid-to-long-term postoperative risk prediction for mortality or dialysis after non-cardiac surgery. Our calculator helps clinicians easily predict a mid-to-long-term risk and PO-AKI occurrence by entering a few variables.

Indexed as

acute kidney injuryforecastinglong term adverse effectpostoperative

Identifiers

PMID40322677
PMCPMC12044331

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.